"The company will hold an investor teleconference at 9.30am tomorrow after release of the announcement to discuss the results."
That is a strange time to hold the conference call, you would think 8:30( Or better still tonight) would be more appropriate- it's now going to run into tomorrow's open...
"Pharmaxis Ltd (PXS) expects to complete its analysis and announce the results of its Phase III clinical trial of Bronchitol in patients with bronchiectasis prior to opening of the market tomorrow, 24 April 2013"
It's interesting that they keep referring to their analysis, like it actually taking some time to work out.
PXS Price at posting:
31.5¢ Sentiment: None Disclosure: Held
